Cell-penetrable nanobodies (transbodies) that inhibit the tyrosine kinase activity of EGFR leading to the impediment of human lung adenocarcinoma cell motility and survival

بواسطة Lueacha Tabtimmai, Praphasri Suphakun, Pimonwan Srisook, Duangnapa Kiriwan, Siratcha Phanthong, Pichamon Kiatwuthinon, Wanpen Chaicumpa, Kiattawee Choowongkomon
منشور في 2020